Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.2495 EUR 2.25% Market Closed
Market Cap: 31.1m EUR

P/OCF
Price to OCF

-2
Current
-2.8
Median
19.8
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-2
=
Market Cap
31.1m EUR
/
Operating Cash Flow
-15.8m EUR
Market Cap P/OCF
FR
Gensight Biologics SA
PAR:SIGHT
31.1m EUR -2
FR
Pharnext SCA
OTC:PNEXF
6T USD -229 143.6
US
Abbvie Inc
NYSE:ABBV
373.8B USD 19.9
US
Amgen Inc
NASDAQ:AMGN
168.4B USD 14.7
US
Gilead Sciences Inc
NASDAQ:GILD
138.9B USD 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.7B USD -263.3
US
Epizyme Inc
F:EPE
94.1B EUR -490.9
AU
CSL Ltd
ASX:CSL
121.1B AUD 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.1B USD 16.5
US
Seagen Inc
F:SGT
39.3B EUR -79.2
NL
argenx SE
XBRU:ARGX
32.9B EUR -138.1
 
FR
Gensight Biologics SA
PAR:SIGHT
Average P/OCF: 18
Negative Multiple: -2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -229 143.6
US
Abbvie Inc
NYSE:ABBV
19.9
US
Amgen Inc
NASDAQ:AMGN
14.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -490.9
AU
CSL Ltd
ASX:CSL
25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -79.2
NL
argenx SE
XBRU:ARGX
Negative Multiple: -138.1

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A